
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+37
Cellipont Bioservices is a cell therapy CDMO in the development and small-to-large batch manufacturing of cell therapies. Our leaders have played an instrumental role in shaping cell therapy development and manufacturing methods and technologies, and our technically-strong team has been recognized by customers and technology partners for its ability to productively grow challenging cells. Cellipont is driven to help our clients to expand patient access to life-changing medicines through best-in-class development, analytical and manufacturing capabilities. We are a small company with a culture that is extremely responsive and customer-centric. Despite our size, Cellipont Bioservices has very deep technical experience, including...
Cell therapy manufacturing,car-t,nkcells,analytical development,process development,manufacturing,pre-clinical to commercial,cdmo expertise,program mangement,fda experience,pai experience,supply chain,t-cells ,tech transfers,validation,eqms,fda audits,quality control,quality assurance,cell banking,mscs,hscs,feeder cell banks,fibroblasts,dendritic cells,tils,fill/finish,stability testing,gap analysis,scale up,feasibility runs,process verification,autologous ,allogeneic ,patient first,improving patient lives,purpose built facility,innovative technology,building partnerships,business development,dmso,and non-dmso
Cellipont bioservices operates in the Biotechnology research industry.
Cellipont bioservices's revenue is 11m - 100m
Cellipont bioservices has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.